The use of contrast harmonic-endoscopic ultrasound (CH-EUS) in routine clinical practice is increasing rapidly but is not yet standardized. We present the levels of evidence (LEs) classification of the literature to put its clinical outcomes in the appropriate perspective.

Fusaroli, P., Napoleon, B., Gincul, R., Lefort, C., Palazzo, L., Palazzo, M., et al. (2016). The clinical impact of ultrasound contrast agents in EUS: a systematic review according to the levels of evidence. GASTROINTESTINAL ENDOSCOPY, 84, 587-596 [10.1016/j.gie.2016.06.006].

The clinical impact of ultrasound contrast agents in EUS: a systematic review according to the levels of evidence

FUSAROLI, PIETRO;CALETTI, GIANCARLO;LISOTTI, ANDREA
2016

Abstract

The use of contrast harmonic-endoscopic ultrasound (CH-EUS) in routine clinical practice is increasing rapidly but is not yet standardized. We present the levels of evidence (LEs) classification of the literature to put its clinical outcomes in the appropriate perspective.
2016
Fusaroli, P., Napoleon, B., Gincul, R., Lefort, C., Palazzo, L., Palazzo, M., et al. (2016). The clinical impact of ultrasound contrast agents in EUS: a systematic review according to the levels of evidence. GASTROINTESTINAL ENDOSCOPY, 84, 587-596 [10.1016/j.gie.2016.06.006].
Fusaroli, Pietro; Napoleon, Bertrand; Gincul, Rodica; Lefort, Christine; Palazzo, Laurent; Palazzo, Maxime; Kitano, Masayuki; Minaga, Kosuke; Caletti, Giancarlo; Lisotti, Andrea
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/576473
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 32
  • Scopus 80
  • ???jsp.display-item.citation.isi??? 72
social impact